X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (211) 211
life sciences & biomedicine (204) 204
humans (170) 170
cardiovascular system & cardiology (155) 155
cardiac & cardiovascular systems (141) 141
male (118) 118
female (115) 115
life sciences (83) 83
middle aged (78) 78
aged (74) 74
cardiovascular (74) 74
treatment outcome (56) 56
cardiology and cardiovascular medicine (50) 50
abridged index medicus (48) 48
ticlopidine - analogs & derivatives (48) 48
human health and pathology (47) 47
acute coronary syndrome (44) 44
prospective studies (44) 44
risk factors (42) 42
percutaneous coronary intervention (41) 41
stents (41) 41
platelet aggregation inhibitors - therapeutic use (40) 40
coronary heart disease (35) 35
acute coronary syndromes (34) 34
time factors (29) 29
cardiology and cardiovascular system (28) 28
peripheral vascular disease (28) 28
platelet aggregation inhibitors - administration & dosage (27) 27
adult (24) 24
follow-up studies (24) 24
internal medicine (24) 24
acute coronary syndrome - drug therapy (23) 23
acute coronary syndrome - therapy (23) 23
care and treatment (23) 23
child (23) 23
clopidogrel (23) 23
heart attacks (23) 23
ticlopidine - therapeutic use (23) 23
blood platelets (22) 22
drug therapy (22) 22
thrombosis (22) 22
[sdv]life sciences [q-bio] (21) 21
risk assessment (21) 21
acute coronary syndrome - blood (20) 20
platelet aggregation inhibitors - adverse effects (20) 20
ticlopidine - administration & dosage (20) 20
stent (19) 19
adolescent (18) 18
analysis (18) 18
cardiology (18) 18
aged, 80 and over (17) 17
blood platelets - drug effects (17) 17
platelet aggregation - drug effects (17) 17
aspirin (16) 16
hematology (16) 16
hemorrhage - chemically induced (16) 16
platelet function tests (16) 16
transluminal angioplasty (16) 16
coronary artery disease (15) 15
drug therapy, combination (15) 15
platelet reactivity (15) 15
[sdv.mhep.csc]life sciences [q-bio]/human health and pathology/cardiology and cardiovascular system (14) 14
coronary angiography (14) 14
coronary artery disease - therapy (14) 14
genetics (14) 14
prasugrel (14) 14
prasugrel hydrochloride (14) 14
bleeding (13) 13
cardiac patients (13) 13
cardiovascular disease (13) 13
france (13) 13
genetics & heredity (13) 13
mortality (13) 13
prognosis (13) 13
studies (13) 13
young adult (13) 13
aspirin - administration & dosage (12) 12
coronary vessels (12) 12
drug dosages (12) 12
hemorrhage (12) 12
patient outcomes (12) 12
platelet activation - drug effects (12) 12
acute coronary syndrome - surgery (11) 11
angioplasty, balloon, coronary (11) 11
child, preschool (11) 11
drug-eluting stents (11) 11
genotype (11) 11
human genetics (11) 11
infant (11) 11
medical research (11) 11
predictive value of tests (11) 11
purinergic p2y receptor antagonists - therapeutic use (11) 11
adenosine diphosphate (10) 10
angina pectoris (10) 10
aspirin - therapeutic use (10) 10
dose-response relationship, drug (10) 10
myocardial infarction (10) 10
percutaneous coronary intervention - adverse effects (10) 10
ticlopidine - adverse effects (10) 10
body mass index (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9979, pp. 1748 - 1757
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2010, Volume 56, Issue 12, pp. 919 - 933
Journal Article
European heart journal, ISSN 0195-668X, 2016, Volume 37, Issue 3, pp. 267 - +
Cangrelor | Angioplasty | Anticoagulation | Bivalirudin | Nitrates | Rhythm monitoring | Dabigatran | Platelet inhibition | Stent | European society of cardiology | Guidelines | Recommendations | Rivaroxaban | Vorapaxar | Apixaban | Fondaparinux | Ticagrelor | Revascularization | Aspirin | Acute cardiac care | Unstable angina | Enoxaparin | Myocardial ischaemia | Beta-blockers | High-sensitivity troponin | Statin | Atherothrombosis | Glycoprotein IIb/IIIa inhibitors | Prasugrel | Early invasive strategy | Clopidogrel | Non-ST-elevation myocardial infarction | Bypass surgery | Chest pain unit | Diabetes | Heparin | Acute coronary syndromes | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Biomarkers - metabolism | Risk Assessment - methods | Diagnosis, Differential | Physical Examination - methods | Humans | Anticoagulants - therapeutic use | Hemorrhage - prevention & control | Long-Term Care | Angina Pectoris - etiology | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Cardiotonic Agents - therapeutic use | Algorithms | Coronary Angiography - methods | Percutaneous Coronary Intervention - methods | Acute Coronary Syndrome - diagnosis | Electrocardiography | Non-ST Elevated Myocardial Infarction - therapy | Acute Coronary Syndrome - therapy | Platelet Aggregation Inhibitors - therapeutic use | Non-ST Elevated Myocardial Infarction - diagnosis | Purinergic P2Y Receptor Antagonists - therapeutic use | Index Medicus | Anticoagulants | Risk Assessment | Angina Pectoris | Platelet Glycoprotein GPIIb-IIIa Complex | Hemorrhage | Cardiotonic Agents | Life Sciences | Coronary Angiography | Human health and pathology | Non-ST Elevated Myocardial Infarction | Platelet Aggregation Inhibitors | Biomarkers | Physical Examination | Purinergic P2Y Receptor Antagonists | Percutaneous Coronary Intervention | Cardiology and cardiovascular system | Acute Coronary Syndrome
Journal Article
Journal Article